PubMed:31655933 / 645-1054 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T50	7-10	DISEASE	denotes	: J
T51	9-13	DISEASE	denotes	JSLE
T52	25-39	DISEASE	denotes	th active dise
T53	28-42	MPA	denotes	active disease
T54	76-85	POSREG	denotes	increased
T55	86-90	GENE	denotes	sMer
T56	91-97	MPA	denotes	levels
T57	168-184	DISEASE	denotes	nd inactive dise
T58	171-187	MPA	denotes	inactive disease
T59	222-226	GENE	denotes	sMer
T60	227-233	MPA	denotes	levels
T61	234-244	REG	denotes	correlated
T62	250-259	MPA	denotes	SLEDAI-2K
T63	287-290	MPA	denotes	ESR
T64	319-323	GENE	denotes	sAxl
T65	324-334	REG	denotes	correlated
T66	340-349	MPA	denotes	SLEDAI-2K
T67	376-385	MPA	denotes	C4 levels
R89	T51	T53	ThemeOf	JSLE,active disease
R90	T51	T54	ThemeOf	JSLE,increased
R91	T51	T56	ThemeOf	JSLE,levels
R92	T53	T54	ThemeOf	active disease,increased
R93	T56	T54	ThemeOf	levels,increased
R94	T55	T54	ThemeOf	sMer,increased
R95	T55	T56	ThemeOf	sMer,levels
R102	T62	T65	ThemeOf	SLEDAI-2K,correlated
R103	T63	T61	ThemeOf	ESR,correlated
R104	T63	T65	ThemeOf	ESR,correlated
R105	T64	T61	ThemeOf	sAxl,correlated
R106	T64	T65	ThemeOf	sAxl,correlated
R107	T66	T65	ThemeOf	SLEDAI-2K,correlated
R108	T67	T65	ThemeOf	C4 levels,correlated
R96	T58	T54	ThemeOf	inactive disease,increased
R97	T59	T60	ThemeOf	sMer,levels
R98	T59	T61	ThemeOf	sMer,correlated
R99	T60	T61	ThemeOf	levels,correlated
R100	T62	T60	ThemeOf	SLEDAI-2K,levels
R101	T62	T61	ThemeOf	SLEDAI-2K,correlated

Id	Subject	Object	Predicate	Lexical cue
T7	0-409	Sentence	denotes	RESULTS: JSLE patients with active disease (SLEDAI-2K> 4) had significantly increased sMer levels compared with healthy controls (median 8.4 vs. 6.0 ng/mL, p = 0.009) and inactive disease patients (5.2 ng/mL, p = 0.0003). sMer levels correlated with SLEDAI-2K (r = 0.44; p = 0.0004) and ESR (r = 0.24; p = 0.04), while sAxl correlated with SLEDAI-2K (r = 0.33; p = 0.008) and C4 levels (r = - 0.24; p = 0.04).
T7	0-409	Sentence	denotes	RESULTS: JSLE patients with active disease (SLEDAI-2K> 4) had significantly increased sMer levels compared with healthy controls (median 8.4 vs. 6.0 ng/mL, p = 0.009) and inactive disease patients (5.2 ng/mL, p = 0.0003). sMer levels correlated with SLEDAI-2K (r = 0.44; p = 0.0004) and ESR (r = 0.24; p = 0.04), while sAxl correlated with SLEDAI-2K (r = 0.33; p = 0.008) and C4 levels (r = - 0.24; p = 0.04).